Rheon develops first-in-class glaucoma drainage device (GDD), which is externally adjustable to achieve optimal intraocular pressure (IOP).
Rheon capitalizes on emerging trend of treating glaucoma with aqueous shunt technology. All current glaucoma drainage devices are passive devices, providing no control on the drainage rate. They all suffer from high complication rates (>30%), resulting from hypotony (lower than optimal pressure) in the early post-surgery period. Rheon’s shunt, the only externally adjustable device, provides optimal pressure control, eliminating all complications.